The quality policy of Polifarma Pharmaceutical as the sole local manufacturer among those
who supply parenteral solutions in Turkish medical industry, is in conformity with c-GMP
(current Good Manufacturing Practices), a policy that has been introduced by World Health
Organization and supported by Ministry of Health, Republic of Turkey, conducted with the
work flow undertaken by the expert employees by means of modern technology, as the
manufacturer on the cause of being disposal at the human being.
All current practices are monitored in consideration of the fact that the health does not
tolerate the second quality and the serums administered to the patients via vascular system
are manufactured under established standards and marketed.
The inspections after the production process that has been the most important step in
achievement the high quality are conducted on living subjects (rabbits) and introduced
following teh achievement of current good practices.
Having adoptedproviding ease of use on behalf of the patient as being embedded into the
quality policy, Polifarma consistently advocates to the development and increase its
product range.
It is among our company’s priorities to achieve teh highest customer satisfaction by
pursuing a vision of focus on the effective quality system application and monitoring in the
process of product preparation phase down to the marketing of the products.
It is our employee’s responsibility to have all departments taking part in the production
process behaving in line with the quality targets and refraining their target on continuous
base.
|
